Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
LOADING
|||
Revenue Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
9.99%
↑ 208% above average
Average (39q)
3.25%
Historical baseline
Range
High:23.91%
Low:-22.81%
CAGR
-1.8%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 9.99% |
| Q2 2025 | 2.28% |
| Q1 2025 | -8.58% |
| Q4 2024 | -1.22% |
| Q3 2024 | 3.52% |
| Q2 2024 | 6.14% |
| Q1 2024 | -3.52% |
| Q4 2023 | -1.36% |
| Q3 2023 | 23.91% |
| Q2 2023 | 4.06% |
| Q1 2023 | 3.70% |
| Q4 2022 | 12.40% |
| Q3 2022 | -2.70% |
| Q2 2022 | 2.57% |
| Q1 2022 | -0.43% |
| Q4 2021 | 7.74% |
| Q3 2021 | 10.36% |
| Q2 2021 | -1.32% |
| Q1 2021 | 7.40% |
| Q4 2020 | 14.97% |
| Q3 2020 | -2.77% |
| Q2 2020 | 1.32% |
| Q1 2020 | 1.57% |
| Q4 2019 | 4.05% |
| Q3 2019 | 1.38% |
| Q2 2019 | -0.93% |
| Q1 2019 | -11.04% |
| Q4 2018 | 18.73% |
| Q3 2018 | 6.34% |
| Q2 2018 | 21.66% |
| Q1 2018 | -3.33% |
| Q4 2017 | 4.29% |
| Q3 2017 | -11.15% |
| Q2 2017 | 15.03% |
| Q1 2017 | -10.82% |
| Q4 2016 | -1.06% |
| Q3 2016 | -5.60% |
| Q2 2016 | 14.60% |
| Q1 2016 | -22.81% |
| Q4 2015 | 20.42% |